Table 1.
Comparative analysis of quantitative variables between sample groups.
| Variables | Control | BPH | PCa | p | p1 | p2 | p3 | |||
|---|---|---|---|---|---|---|---|---|---|---|
| N | Values | N | Values | N | Values | |||||
| Age (years) | 82 | 60.82 ± 9.41 | 90 | 69.80 ± 8.12 | 44 | 71.27 ± 7.64 | <0.01 | <0.05 | <0.05 | >0.05 |
| BMI (kg) | 75 | 26.12 ± 3.35 | 84 | 26.26 ± 3.93 | 24 | 27.35 ± 3.83 | 0.509 | >0.05 | >0.05 | >0.05 |
| PSAT (ng/mL) | 82 | 0.00 ± 0.87 | 90 | 2.54 ± 3.76 | 44 | 11.52 ± 16.95 | <0.01 | — | — | — |
| PSAF (ng/mL) | 82 | 0.00 ± 0.23 | 90 | 0.43 ± 0.69 | 44 | 0.00 ± 1.29 | <0.01 | — | — | — |
| Prostate weight (g) | 21 | 30.15 ± 9.87 | 52 | 49.28 ± 21.54 | 20 | 46.30 ± 26.30 | 0.947 | <0.05 | <0.05 | >0.05 |
Note: values indicate median ± interquartile range; p is the probabilistic value used to measure the significance of differences between the means of variables. p1 is the probabilistic value used to measure the significance of differences between the control and BPH groups. p2 is the probabilistic value used to measure the significance of differences between the control and PCa groups. p3 is the probabilistic value used to measure the significance of differences between the BPH and PCa groups. Some variables were not passed on in part of the studied group. PSAT: total prostate specific antigen; PSAF: free prostate specific antigen; SBP: systolic blood pressure; DBP: diastolic blood pressure; BMI: body mass index; source: elaborated by the author.